Summary: Newsweek features the world’s first clinical trials researching MDMA as an adjunct to psychotherapy as a potential treatment for alcoholism. MDMA researchers from Imperial College London are leading the clinical trials in the UK. “[MDMA] is able to break down many of the fear barriers that individuals may experience during therapy,” reports Newsweek.